- Report
- October 2024
- 184 Pages
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 198 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 144 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- June 2025
- 158 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- May 2025
- 191 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- February 2025
- 185 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- January 2024
- 303 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- February 2024
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- May 2024
- 240 Pages
Global
From €4474EUR$4,995USD£3,814GBP
- Report
- October 2024
- 88 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- January 2025
- 132 Pages
Global
From €851EUR$950USD£725GBP
The Dengue Test market is a subset of the Diagnostics industry, which focuses on the detection and diagnosis of diseases. Dengue is a mosquito-borne viral infection that is endemic in tropical and subtropical regions. Diagnostic tests for dengue are used to detect the presence of the virus in a patient's blood sample. These tests are used to diagnose dengue fever, as well as to differentiate between the four serotypes of the virus.
The Dengue Test market is driven by the increasing prevalence of dengue fever, as well as the growing demand for rapid and accurate diagnostic tests. The market is also driven by the increasing availability of diagnostic kits and the development of new technologies for the detection of dengue.
Some of the major players in the Dengue Test market include Abbott Laboratories, Bio-Rad Laboratories, DiaSorin, F. Hoffmann-La Roche, and Siemens Healthineers. Show Less Read more
